ASHP Pharmacy Futures Meeting and Exhibition - American Society of Health System Pharmacists Summer Meeting and Exhibition

Expert emphasizes that it is important to acknowledge the critical role of pharmacists in overcoming barriers to vaccinations.

Aimee Banks, PharmD, BCPS, MSCS, clinical pharmacist in the Multiple Sclerosis Clinic at Vanderbilt University Medical Center, discusses new hematology, oncology, and autoimmune therapies in the pipeline that pharmacists should be aware of.

The American Society of Health-System Pharmacists’ conference includes educational opportunities that feature the latest products, services, and technology in the industry.

Workflow in the clinic and the pharmacy are critical for the implementation of a new and novel medication therapy, such as cabotegravir-rilpivirine.

Research presented at the 2021 American Society of Health-System Pharmacists (ASHP) Specialty Pharmacy Conference suggests overall medical expenses for oncology patients were significantly improved by using an integrated health-system specialty pharmacy (HSSP) care model.

The objective of the study was to design and implement a useful tool to record ambulatory metrics that is reportable and can be easily integrated into the clinical workflow.

The American Society of Health-System Pharmacists’ (ASHP) first annual survey of health-system specialty pharmacies (HSSPs) offered insights into the concerns of specialty pharmacists and provided an opportunity for professionals in the field to outline a potential future for specialty pharmacy.

The pipeline for biosimilar products in the United States includes at least 26 candidates in phase 3 trials for 13 reference therapies.

White continued to discuss how being self-aware, using the right language, modeling behaviors that support belonging, and fostering an environment with psychological safety is the goal as a a health care provider.

In one program, hospital pharmacists received alerts whenever an antiretroviral was prescribed in the emergency department, enabling prompt action.

Specialty pharmacists have the expertise and respect necessary to change the health care system while listening to patients’ needs and guiding them through difficult experiences.

Lindsay Davis, PharmD, BCPS, ASH-CHC, TTS and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, both professors at t Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discuss pharmacists as patient care providers, and managing patients taking anticoagulation medications.

A recent study found that Integrating smart pump infusions with electronic health records results in fewer errors when administering medication, but does not eliminate them entirely

Many health systems are still unaware of the role of a psychiatric pharmacist provider. Tera Moore, PharmD, discusses strategies for increasing awareness.

Rapid diagnostic testing resulted in providers receiving a large increase in pharmacist recommendations in 2 community hospital settings.

Patricia Kienle, BSPHARM, MPA, FASHP, discusses how and why compounding pharmacies should work with interdisciplinary teams on issues of patient safety.

Lindsay Davis and Elizabeth Pogge, of the Midwestern University College of Pharmacy-Glendale, discuss key tips for how pharmacists can be impactful for their patients.

Study authors saw a 15% increase in patients during the study period, including a 27% increase in children and a 20% increase in patients over age 60 years.

Patricia Kienle, BSPHARM, MPA, FASHP, discusses how pharmacists can be key players in maintaining safe, sterile compounding standards throughout an entire health system.

David Hager, PharmD, BCPS, Director, Clinical Pharmacy Services, University of Wisconsin Health, Madison, WI, discusses behaviors that practice stewardship through leadership.

Tom Kraus, VP of Government Relations for the American Society of Health-System Pharmacists (ASHP), discusses patient and drug safety advocacy with drug importation.

Tera Moore, PharmD, National Program Manager, VA Pharmacy Benefits Management office, explains the benefits of psychiatric pharmacist providers for patients and interprofessional practice.

David Hager, PharmD, BCPS, Director, Clinical Pharmacy Services, University of Wisconsin Health, Madison, WI, discusses the philosophy of leading a pharmacy team with stewardship.

Linking smart pumps with electronic health records could drastically lessen the likelihood of an infusion-based ADE.

Tom Kraus, VP of Government Relations for ASHP, speaks about what pharmacists should look for in a robust provider status law.

A retrospective study by Intermountain Healthcare Research found statistical significance between the rate of patients receiving naloxone with opioid prescriptions at health system pharmacies when compared to non-health system pharmacies. .

With the implementation of telehealth video visits in the ambulatory care pharmacy space, care can be expanded to include patients previously unable to attend in-person appointments.

Tera Moore, PharmD, discusses key strategies for successfully integrating psychiatric pharmacist providers in mental healthcare teams.

Tom Kraus, of ASHP, says pharmacists should play an active role in advocating for policy changes and legislative actions.

Tera Moore, National Program Manager with the VA Pharmacy Benefits Management Clinical Pharmacy Practice Office, discusses the role that psychiatric pharmacist providers play in their patients' mental health management.